Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing-Reference-Cited by-同舟云学术

Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 Editing

Published:2018-12 Issue:6 Volume:155 Page:1967-1970.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Pankowicz Francis P.,Barzi Mercedes,Kim Kang Ho,Legras Xavier,Martins Celeste Santos^ORCID,Wooton-Kee Clavia Ruth,Lagor William R.,Marini Juan C.,Elsea Sarah H.,Bissig-Choisat Beatrice,Moore David D.,Bissig Karl-Dimiter

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Tissue- and site-specific DNA recombination in transgenic mice;Orban;Proc Natl Acad Sci U S A,1992

2. Targeted oncogene activation by site-specific recombination in transgenic mice;Lakso;Proc Natl Acad Sci U S A,1992

3. Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice;Ruppert;Genes Dev,1992

4. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice;Grompe;Genes Dev,1993

5. Murine fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus;Klebig;Proc Natl Acad Sci U S A,1992

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma;Asian Journal of Pharmaceutical Sciences;2023-07

2. Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances;Pharmaceutics;2023-03-31

3. Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications;Genes;2023-02-14

4. Rapid in vivo multiplexed editing (RIME) of the adult mouse liver;Hepatology;2022-10-13

5. Genome‐Editing Applications in Stem Cell Engineering and Regenerative Medicine;Genome Editing in Drug Discovery;2022-03-17